Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer. | Comput Math Methods Med | 2022 | 35069784 | PubTator, text mining | PubMed |
| The regulation of PBXs and their emerging role in cancer. | J Cell Mol Med | 2022 | 35068042 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
| Epigenome-Wide DNA Methylation Profiling in Colorectal Cancer and Normal Adjacent Colon Using Infinium Human Methylation 450K. | Diagnostics (Basel) | 2022 | 35054365 | PubTator, text mining | PubMed |
| Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways. | Cells | 2022 | 35053339 | PubTator, text mining | PubMed |
| Genome-Wide Analysis in Drosophila Reveals the Genetic Basis of Variation in Age-Specific Physical Performance and Response to ACE Inhibition. | Genes (Basel) | 2022 | 35052483 | PubTator, text mining | PubMed |
| Discovery of natural product-like spirooxindole derivatives as highly potent and selective LSD1/KDM1A inhibitors for AML treatment. | Bioorg Chem | 2022 | 35051709 | PubTator, text mining | PubMed |
| Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. | NPJ Breast Cancer | 2022 | 35042871 | PubTator, text mining | PubMed |
| Identification of Hox genes and their expression profiles during embryonic development of the emerging model organism, Macrobrachium olfersii. | J Exp Zool B Mol Dev Evol | 2022 | 35037742 | PubTator, text mining | PubMed |
| Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation. | iScience | 2022 | 35036869 | PubTator, text mining | PubMed |
Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis. | Bioengineered | 2022 | 35034547 | PubTator, text mining | PubMed |
| MiR-195-3p is a Novel Prognostic Biomarker Associated with Immune Infiltrates of Lung Adenocarcinoma. | Int J Gen Med | 2022 | 35023957 | PubTator, text mining | PubMed |
| Differential roles of BAF and PBAF subunits, Arid1b and Arid2, in MLL-AF9 leukemogenesis. | Leukemia | 2022 | 35022500 | PubTator, text mining | PubMed |
| Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia. | Blood Cancer Discov | 2022 | 35019859 | PubTator, text mining | PubMed |
| Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c). | Blood Cancer J | 2022 | 35017466 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins. | Int J Mol Sci | 2022 | 35008940 | PubTator, text mining | PubMed |
| LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation. | J Clin Invest | 2022 | 34990402 | PubTator, text mining | PubMed |
| GFI1 Cooperates with IKZF1/IKAROS to Activate Gene Expression in T-cell Acute Lymphoblastic Leukemia. | Mol Cancer Res | 2022 | 34980595 | PubTator, text mining | PubMed |
| Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer. | Mol Ther Nucleic Acids | 2022 | 34938606 | PubTator, text mining | PubMed |
| Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma. | Mol Oncol | 2022 | 34919784 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=50